BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8392631)

  • 1. A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.
    Moscufo N; Yafal AG; Rogove A; Hogle J; Chow M
    J Virol; 1993 Aug; 67(8):5075-8. PubMed ID: 8392631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles.
    Tuthill TJ; Bubeck D; Rowlands DJ; Hogle JM
    J Virol; 2006 Jan; 80(1):172-80. PubMed ID: 16352541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus.
    Danthi P; Tosteson M; Li QH; Chow M
    J Virol; 2003 May; 77(9):5266-74. PubMed ID: 12692228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryo-electron microscopy reconstruction shows poliovirus 135S particles poised for membrane interaction and RNA release.
    Butan C; Filman DJ; Hogle JM
    J Virol; 2014 Feb; 88(3):1758-70. PubMed ID: 24257617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
    Fricks CE; Hogle JM
    J Virol; 1990 May; 64(5):1934-45. PubMed ID: 2157861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structures reveal two distinct conformational states in a picornavirus cell entry intermediate.
    Shah PNM; Filman DJ; Karunatilaka KS; Hesketh EL; Groppelli E; Strauss M; Hogle JM
    PLoS Pathog; 2020 Sep; 16(9):e1008920. PubMed ID: 32997730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
    Moscufo N; Chow M
    J Virol; 1992 Dec; 66(12):6849-57. PubMed ID: 1331497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Imaging of Polioviral RNA Translocation across a Membrane.
    Karunatilaka KS; Filman DJ; Strauss M; Loparo JJ; Hogle JM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    Marc D; Masson G; Girard M; van der Werf S
    J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes.
    Bubeck D; Filman DJ; Cheng N; Steven AC; Hogle JM; Belnap DM
    J Virol; 2005 Jun; 79(12):7745-55. PubMed ID: 15919927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An externalized polypeptide partitions between two distinct sites on genome-released poliovirus particles.
    Lin J; Cheng N; Chow M; Filman DJ; Steven AC; Hogle JM; Belnap DM
    J Virol; 2011 Oct; 85(19):9974-83. PubMed ID: 21775460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold-adapted poliovirus mutants bypass a postentry replication block.
    Dove AW; Racaniello VR
    J Virol; 1997 Jun; 71(6):4728-35. PubMed ID: 9151866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the 135S poliovirus particle an intermediate during cell entry?
    Huang Y; Hogle JM; Chow M
    J Virol; 2000 Sep; 74(18):8757-61. PubMed ID: 10954579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.
    Hindiyeh M; Li QH; Basavappa R; Hogle JM; Chow M
    J Virol; 1999 Nov; 73(11):9072-9. PubMed ID: 10516013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.
    Belnap DM; Filman DJ; Trus BL; Cheng N; Booy FP; Conway JF; Curry S; Hiremath CN; Tsang SK; Steven AC; Hogle JM
    J Virol; 2000 Feb; 74(3):1342-54. PubMed ID: 10627545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.
    Strauss M; Filman DJ; Belnap DM; Cheng N; Noel RT; Hogle JM
    J Virol; 2015 Apr; 89(8):4143-57. PubMed ID: 25631086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry.
    Danthi P; Chow M
    J Virol; 2004 Jan; 78(1):33-41. PubMed ID: 14671085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating.
    Pelletier I; Ouzilou L; Arita M; Nomoto A; Colbère-Garapin F
    Virology; 2003 Jan; 305(1):55-65. PubMed ID: 12504541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.